Member Info for Goldsmith99

Fum moves fast watch this space , upside is massive

offer just ticked up gla

is this the bounce ?

Synairgen, a University of Southampton spin-out, had earlier focused SNG001 at asthma and COPD, and its greatest success until now was a $7m tie-up with Astrazeneca. Perhaps the Covid-19 data will attract further funding, though this will likely come from investors; the UK government has so far focused its spending efforts largely on securing vaccine supply.

Home trials would need second wave for more data

Look at my earlier post

https://www.evaluate.com/vantage/articles/news/trial-results/synairgen-joins-2020-coronavirus-winners-club

i think it would be nice to clarify that we dont have any fundraising issues by the board ?

do we have enough cash to take this to the next level ?

for manufacturing

getting tired of this now

im holding

beware

beware its that time

joke just as we are going places will this impact future revenue ?

uk has already ordered

https://www.bbc.co.uk/news/health-53469269

beware of the profit taking

is that a signal

what a dump